New MRI scan could spot hidden heart problems without gadolinium
NCT ID NCT06731738
First seen Jan 09, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This study tested a new MRI technique using a manganese-based contrast agent to measure how well heart cells take up manganese. It included 44 healthy volunteers and heart failure patients with preserved ejection fraction caused by hypertrophic cardiomyopathy or cardiac amyloidosis. The goal was to see if this method can detect cell function problems separate from scarring, which could improve diagnosis and treatment monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oslo University Hospital, Department of Cardiology, Rikshospitalet Sognsvannsveien 20
Oslo, Oslo, 0372, Norway
Conditions
Explore the condition pages connected to this study.